Cargando...
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
BACKGROUND: Metformin use has been associated with a reduced risk of developing cancer and an improvement in overall cancer survival rates in meta-analyses, but, to date, evidence to support the use of metformin as an adjuvant therapy in individual cancer types has not been presented. PATIENTS AND M...
Gardado en:
| Publicado en: | Ann Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5178140/ https://ncbi.nlm.nih.gov/pubmed/27681864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdw410 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|